RACK1 overexpression is linked to more aggressive forms of cancers, including prostate, colorectal, and breast cancers, as well as hepatocellular carcinoma, nasopharyngeal carcinoma, and non-small cell lung cancer [19,22,23,25]. Here, RACK1 is linked to non-small cell lung carcinoma.